• Return to Headlines

Shares of Biospecifics Tec Rank the Lowest in Terms of Future Earnings Growth in the Biotechnology Industry (BSTC, AMGN, GILD, BIIB, REGN)

By Shiri Gupta

Below are the three companies in the Biotechnology industry with the lowest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.

Biospecifics Tec ranks lowest with a future earnings growth of 1.9%. Following is Amgen Inc with a future earnings growth of 3.4%. Gilead Sciences ranks third lowest with a future earnings growth of 4.8%.

Biogen Inc follows with a future earnings growth of 9.5%, and Regeneron Pharm rounds out the bottom five with a future earnings growth of 11.2%.

SmarTrend recommended that its subscribers protect gains by selling shares of Biogen Inc on February 7th, 2019 by issuing a Downtrend alert when the shares were trading at $316.11. Since that call, shares of Biogen Inc have fallen 25.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest future earnings growth biospecifics tec amgen inc Gilead Sciences biogen inc regeneron pharm

Ticker(s): BSTC AMGN GILD BIIB REGN